[Retracted] Diagnostic and prognostic value of contrast‑enhanced ultrasound combined with diffusion‑weighted magnetic resonance imaging in different subtypes of breast cancer.

Int J Mol Med 42: [Related article:] 105‑114, 2018; DOI: 10.3892/ijmm.2018.3591. The authors have requested that their research article entitled 'Diagnostic and prognostic value of contrast‑enhanced ultrasound combined with diffusion‑weighted magnetic resonance imaging in different subtypes of breast cancer' published in International Journal of Molecular Medicine 42, 105‑114, 2018, be retracted. This study was conceived jointly by the research institute of the authors' hospital (Jilin University China‑Japan Friendship Hospital) and the Second Affiliated Hospital of Zhengzhou University, and the clinical data were obtained from the two institutes. It is regrettable that the scientific research unit of the Second Affiliated Hospital of Zhengzhou University did not authorize the publication of these results, and the authors have subsequently received an official request from the Second Affiliated Hospital of Zhengzhou University to retract this paper, since the results of their article have infringed the scientific research rights of the third party. The Editor of International Journal of Molecular Medicine agrees that the article should be retracted from the publication in view of the infringement of the scientific rights of the third party. All the named authors agree to this retraction. The authors apologize to the Editor and to the readership of the Journal, and regret any inconvenience this will cause.